Abstract
Testosterone (T) deficiency is prevalent particularly in elderly men and lead to physical and sexual morbidities. Although low levels of T are associated with low urinary tract symptoms, the correlation between T deficiency and bladder dysfunction is not clearly identified. The aim of this study was to investigate the effect of high dose testosterone replacement therapy (TRT) on the histological structure of the UB in castrated rats. Twenty-five adult male rats were divided into three groups: control, castrated and castrated + TRT. T was administrated in high dose (100 mg/kg) two intramuscular injections/week for 60 days. UB sections were prepared and stained with H&E, Masson’s trichrome and immunohistochemical detection of Cytokeratin 20 (Ck20). All data were morphometrically and statistically analyzed. In castrated group, significant atrophy of the urothelium (P < 0.001) accompanied with widening of the corium were observed. The smooth muscle appeared thin with marked increase in the collagen fibers. On treating the castrated group with TRT, atypical Ck20 expression as well as significant increase in urothelial thickness (P < 0.05) and smooth muscle/collagen ratio (P < 0.001) were detected. In castrated rat model, high dose TRT has a positive effect on the UB smooth muscle rather than the urothelium which acquired atypical patterns.
Similar content being viewed by others
References
Bancroft JD, Layton C (2013) The Hematoxylin and eosin. In: Suvarna SK, Layton C and Bancroft JD (eds), Theory & Practice of histological techniques. 7th ed., Churchill Livingstone of El Sevier, Philadelphia, Ch.10 and 11, pp 173–214
Callies F, Kollenkirchen U, von zur Muhlen C et al (2003) Testosterone undecanoate: a useful tool for testosterone administration in rats. Exp Clin Endocrinol Diabetes 111:203–208
Cayan F, Tek M, Balli E et al (2008) The effect of testosterone alone and testosterone + estradiol therapy on bladder functions and smooth muscle/collagen content in surgically menopause induced rats. Maturitas 60:248–252
Celayir S, Ilce Z, Dervisoglu S (2002) The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects. Eur J Pediatr Surg 12:312–317
Chamness SL, Ricker DD, Crone JK et al (1995) The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101–1107
Chang C, Lee SO, Yeh S et al (2014) Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 33:3225–3234
Corona G, Rastrelli G, Forti G et al (2011) Update in testosterone therapy for men. J Sex Med 8: 639-654; quiz 655
Das AK, Leggett RE, Whitbeck C et al (2002) Effect of doxazosin on rat urinary bladder function after partial outlet obstruction. Neurourol Urodyn 21:160–166
de Barros CA, Lorenzetti F, Ortiz V et al (2013) Testosterone supplementation’s effects on age-related bladder remodeling-experimental study in rats. Aging Male 16:102–107
de Deus JM, Girao MJ, Sartori MG et al (2003) Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene. Am J Obstet Gynecol 189:1654–1659
Filippi S, Morelli A, Sandner P et al (2007) Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148:1019–1029
Gallo CB, Miranda AF, Felix-Patricio B et al (2012) Effects of castration and hormone replacement in the urinary bladder of rats: structural, ultrastructural, and biochemical analysis. J Androl 33:684–690
Giagulli VA, Triggiani V, Carbone MD et al (2011a) The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. J Sex Med 8:3471–3478
Giagulli VA, Triggiani V, Corona G et al (2011b) Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations. Curr Pharm Des 17:1500–1511
Haider A, Gooren LJ, Padungtod P et al (2009) Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia 41:7–13
Hall R, Andrews PLR, Hoyle CHV (2002) Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder. Eur J Pharmacol 449:301–309
Harnden P, Eardley I, Joyce AD et al (1996) Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 78:870–875
Jockenhovel F, Minnemann T, Schubert M et al (2009) Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Eur J Endocrinol 160:815–819
Juan Y-S, Onal B, Broadaway S et al (2007) Effect of castration on male rabbit lower urinary tract tissue enzymes. Mol Cell Biochem 301:227–233
Kalinchenko S, Vishnevskiy EL, Koval AN et al (2008) Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 11:57–61
Karazindiyanoglu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11:146–149
Keast JR (1999) The autonomic nerve supply of male sex organs–an important target of circulating androgens. Behav Brain Res 105:81–92
Koritsiadis G, Stravodimos K, Mitropoulos D et al (2008) Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int 101:1542–1546
Kunju LP, Lee CT, Montie J et al (2005) Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia. Pathol Int 55:248–254
Lang Q, Liu Q, Xu N et al (2011) The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun 409:448–453
Li Y, Izumi K, Miyamoto H (2012) The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol 42:569–577
Litman HJ, Bhasin S, O’Leary MP et al (2007) An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int 100:321–326
Longhurst PA (2003) Functional development of the rat urinary bladder after pre- or postpubertal castration. Pharmacology 67:72–82
Madeiro A, Girao M, Sartori M et al (2002) Effects of the association of androgen/estrogen on the bladder and urethra of castrated rats. Clin Exp Obstet Gynecol 29:117–120
Magari T, Shibata Y, Arai S et al (2014) Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels. Asian J Androl 16:457–460
Mallofre C, Castillo M, Morente V et al (2003) Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod pathol 16:187–191
Matsuoka M, Tsukamoto H (1990) Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599–605
McKenney JK, Desai S, Cohen C et al (2001) Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 25:1074–1078
McVary K (2006) Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 Suppl 2: 23–28; discussion 44–45
Moll R (1991) Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochemica Supplementband 41:117–127
Morita T, Tsuchiya N, Tsujii T et al (1992) Changes of autonomic receptors following castration and estrogen administration in the male rabbit urethral smooth muscle. Tohoku J Exp Med 166:403–405
Nahata A, Dixit VK (2012) Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats. Andrologia 44(Suppl 1):396–409
Pradidarcheep W (2008) Lower urinary tract symptoms and its potential relation with late-onset hypogonadism. Aging Male 11:51–55
Purves-Tyson TD, Arshi MS, Handelsman DJ et al (2007) Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic ganglia. Neuroscience 148:92–9104
Rahman M, Miyamoto H, Chang C (2004) Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. Clin Cancer Res 10:2208–2219
Rees RW, Foxwell NA, Ralph DJ et al (2003) Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol 170:2517–2522
Salmi S, Santti R, Gustafsson JA et al (2001) Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urol 166:674–677
Samarakoon R, Overstreet JM, Higgins SP et al (2012) TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res 347:117–128
Shen Z-J, Zhou X-L, Lu Y-L et al (2003) Effect of androgen deprivation on penile ultrastructure. Asian J Androl 5:33–36
Takyu S (1993) Effects of testosterone on the autonomic receptor-mediated function in lower urinary tract from male rabbits. Nihon Hinyokika Gakkai Zasshi 84:330–338
Tek M, Balli E, Cimen B et al (2010) The effect of testosterone replacement therapy on bladder functions and histology in orchiectomized mature male rats. Urology 75:886–890
Tirabassi G, Delli Muti N, Corona G et al (2014) Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. J Sex Med 11:1302–1308
Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52:54–70
Wen J, Jiang X, Dai Y et al (2010) Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J 24:740–749
Yassin DJ, Doros G, Hammerer PG et al (2014) Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med 11:1567–1576
Zhang Y, Chen J, Hu L et al (2012) Androgen deprivation induces bladder histological abnormalities and dysfunction via TGF-beta in orchiectomized mature rats. Tohoku J Exp Med 226:121–128
Acknowledgments
The authors have not made any acknowledgments.
Conflict of interest
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdel-Hamid, A.A.M., Ali, E.M.T. Effect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats. J Mol Hist 46, 263–272 (2015). https://doi.org/10.1007/s10735-015-9617-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-015-9617-4